Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BCR/ABL-negative chronic myeloproliferative disorders: JAK2 mutation and beyond.

Archives of pathology & laboratory medicine - 1 Aug 2006

Chang Chung-Che Jeff

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Bone Marrow Cells
Share to Cell Proliferation
Share to Genes, abl

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Protein-Tyrosine Kinases

Share to Proto-Oncogene Proteins

Source

Identifiers

PMID: 16879012
DOI: 10.5858/2006-130-1123-ACMD

Genes

BCR
JAK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BCR/ABL-negative chronic myeloproliferative disorders: JAK2 mutation and beyond.PMID 16879012Read ↗

A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospectsSemantic proximity Read ↗

JAK2: implications for diagnosis and classification of myeloproliferative disorders.Semantic proximity Read ↗

[Pathogenetic role of JAK2 gene mutation in chronic myeloproliferative disorders].Semantic proximity Read ↗

[JAK2 mutation in myeloproliferative disorders].Semantic proximity Read ↗

JAK2 inhibitors and myeloproliferative neoplasms.Semantic proximity Read ↗

[Myeloproliferative diseases caused by Jak2 gene mutation].Semantic proximity Read ↗

Jak-2 positive myeloproliferative neoplasms.Semantic proximity Read ↗

<i>JAK2</i>Mutations in Myeloproliferative DisordersSemantic proximity Read ↗

Update on the impact of the JAK2 mutation on signalling pathways in myeloproliferative disorders.Semantic proximity Read ↗

Janus kinase 2 mutations in Philadelphia negative chronic myeloproliferative disorders: clinical implications.Semantic proximity Read ↗

JAK2 V617F: a single mutation in the myeloproliferative group of disorders.Semantic proximity Read ↗

[JAK2 gene mutation in chronic myeloproliferative disorders].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.